Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275
Cardinal Health, Inc.
Cardinal Health, Inc. CAH | 0.00 |
Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:
CAH) with a Overweight and raises the price target from $258 to $275.
